This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arai, T
Right arrow Articles by Mikami, Y
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arai, T
Right arrow Articles by Mikami, Y

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1985 July; 28(1): 5-11

Directed biosynthesis of new saframycin derivatives with resting cells of Streptomyces lavendulae.

T Arai, K Yazawa, K Takahashi, A Maeda and Y Mikami

ABSTRACT

Saframycin A is an antitumor antibiotic produced by Streptomyces lavendulae 314 which falls into the category of the N-heterocyclic quinone group. Biosynthetically the quinone ring is derived from two tyrosine molecules which condense to generate the basic ring system of saframycin A. The side chain also has been found to derive from two amino acids, i.e., glycine and alanine. Supplementation by various amino acid analogs of the side chain produced three new saframycin derivatives with a replaced side chain. These three saframycins, designated Yd-1, Yd-2, and Y3, contained 2-amino-n-butyric acid, glycine, and alanine residues, respectively. in place of the normal N-terminal pyruvic acid in the side chain of saframycin A. Feeding experiments with 13C-labeled dipeptide indicated that the amino acids are probably incorporated in the side chain as a dipeptide unit. It was also found that saframycin A is produced from saframycin Y3 by an enzymatic deamination reaction. Based on these results, saframycin biosynthesis in S. lavendulae is discussed.


Antimicrob Agents Chemother. 1985 July; 28(1): 5-11




This article has been cited by other articles:

  • Li, L., Deng, W., Song, J., Ding, W., Zhao, Q.-F., Peng, C., Song, W.-W., Tang, G.-L., Liu, W. (2008). Characterization of the Saframycin A Gene Cluster from Streptomyces lavendulae NRRL 11002 Revealing a Nonribosomal Peptide Synthetase System for Assembling the Unusual Tetrapeptidyl Skeleton in an Iterative Manner. J. Bacteriol. 190: 251-263 [Abstract] [Full Text]  
  • Nelson, J. T., Lee, J., Sims, J. W., Schmidt, E. W. (2007). Characterization of SafC, a Catechol 4-O-Methyltransferase Involved in Saframycin Biosynthesis. Appl. Environ. Microbiol. 73: 3575-3580 [Abstract] [Full Text]